Sylvest Advisors LLC purchased a new stake in Genpact Limited (NYSE:G - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 17,169 shares of the business services provider's stock, valued at approximately $737,000.
A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. UMB Bank n.a. grew its stake in shares of Genpact by 55.7% in the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider's stock worth $52,000 after purchasing an additional 433 shares during the last quarter. Venturi Wealth Management LLC increased its holdings in Genpact by 74.6% in the third quarter. Venturi Wealth Management LLC now owns 2,623 shares of the business services provider's stock worth $103,000 after purchasing an additional 1,121 shares in the last quarter. GAMMA Investing LLC boosted its holdings in shares of Genpact by 221.3% during the 3rd quarter. GAMMA Investing LLC now owns 3,329 shares of the business services provider's stock worth $131,000 after buying an additional 2,293 shares in the last quarter. Versant Capital Management Inc increased its stake in shares of Genpact by 17.0% in the 4th quarter. Versant Capital Management Inc now owns 3,178 shares of the business services provider's stock valued at $136,000 after acquiring an additional 461 shares in the last quarter. Finally, MassMutual Private Wealth & Trust FSB grew its holdings in Genpact by 22.4% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 3,378 shares of the business services provider's stock worth $145,000 after purchasing an additional 619 shares during the period. 96.03% of the stock is currently owned by institutional investors and hedge funds.
Genpact Price Performance
G traded down $0.06 during trading on Wednesday, reaching $49.30. 482,276 shares of the stock were exchanged, compared to its average volume of 1,320,204. Genpact Limited has a 1 year low of $30.23 and a 1 year high of $49.68. The company has a market capitalization of $8.69 billion, a price-to-earnings ratio of 13.53, a P/E/G ratio of 1.61 and a beta of 1.20. The business's 50 day moving average price is $44.80 and its two-hundred day moving average price is $41.04. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.85 and a quick ratio of 1.85.
Genpact (NYSE:G - Get Free Report) last posted its quarterly earnings results on Thursday, November 7th. The business services provider reported $0.75 EPS for the quarter, topping analysts' consensus estimates of $0.71 by $0.04. The business had revenue of $1.21 billion during the quarter, compared to the consensus estimate of $1.19 billion. Genpact had a return on equity of 21.85% and a net margin of 14.22%. During the same period last year, the firm earned $0.67 earnings per share. As a group, equities research analysts anticipate that Genpact Limited will post 2.94 earnings per share for the current year.
Analyst Ratings Changes
Several analysts have commented on G shares. Needham & Company LLC lifted their price objective on shares of Genpact from $42.00 to $55.00 and gave the stock a "buy" rating in a research report on Monday, November 11th. TD Cowen boosted their target price on Genpact from $40.00 to $45.00 and gave the company a "hold" rating in a research note on Friday, November 8th. Robert W. Baird lifted their price objective on Genpact from $44.00 to $48.00 and gave the stock a "neutral" rating in a report on Friday, November 8th. Finally, Jefferies Financial Group raised shares of Genpact from a "hold" rating to a "buy" rating and upped their price objective for the company from $44.00 to $55.00 in a report on Tuesday, January 21st. Six analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat.com, Genpact has an average rating of "Hold" and an average price target of $44.50.
Read Our Latest Stock Report on Genpact
Insider Buying and Selling
In other Genpact news, CEO Balkrishan Kalra sold 13,600 shares of Genpact stock in a transaction that occurred on Friday, December 13th. The shares were sold at an average price of $44.60, for a total value of $606,560.00. Following the transaction, the chief executive officer now owns 267,404 shares of the company's stock, valued at approximately $11,926,218.40. The trade was a 4.84 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Piyush Mehta sold 12,000 shares of the stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $42.83, for a total value of $513,960.00. Following the transaction, the senior vice president now owns 151,182 shares of the company's stock, valued at approximately $6,475,125.06. The trade was a 7.35 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 35,058 shares of company stock valued at $1,558,675. Company insiders own 2.80% of the company's stock.
Genpact Company Profile
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Articles

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.